Infectious Diseases

Host: Andrew Wilner, MD, FACP, FAAN

Guest: William W. Li, MD

As the number of new COVID-19 infections continues to decrease and the United States begins to open back up, it’s important to note that there are patients who have survived COVID-19 but are still suffering. The newly coined term “COVID long-haulers” refers to those patients who continue to have symptoms even after the acute infection is resolved. Joining Dr. Andrew Wilner to share what we know so far about COVID long-haulers and how we can help them is vascular biologist Dr. William Li.

Host: John Russell, MD

Guest: Paul Farmer, MD, PhD

Dr. John Russell meets with Dr. Paul Farmer, the Chair of Global Health at Harvard Medical School and co-founder of Partners in Health, to review past pandemics and outbreaks while discussing things we can do as a community to lower the risk of these events.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Chris H. Cooper

Can new mask technology made with innovative materials better protect us from the coronavirus? Dr. Charles Turck speaks with Chris Cooper, Chief Science Officer and CEO of Airlock389, on improving mask technology after the supply shortage of masks during COVID-19.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Russell D. Cohen, MD, FACG, AGAF

Are patients with inflammatory bowel disease (IBD) at increased risk for COVID-19 infection? And what should we recommend for an IBD patient in remission who tests positive for COVID-19 versus a patient with active disease? These are just some of the questions that have arisen since the onset of the COVID-19 pandemic, and the questions Dr. Peter Buch explores with Dr. Russell Cohen, Director of Inflammatory Bowel Disease Center and Co-Director of the Advanced IBD Fellowship Program at the University of Chicago School of Medicine.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Ana C Zamora Martinez, MD

The COVID-19 pandemic led many clinicians to make life-altering decisions. Dr. Ana Zamora, a pulmonary disease and critical care specialist, discusses her work with Locum Tenens and why she decided it was time for a change.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Asher A. Kornbluth, MD

Since the onset of the COVID-19 pandemic, many questions have arisen regarding the care of our patients with IBD. Are they at increased risk of COVID-19? How should we treat a patient with IBD who has active COVID-19? Should they get vaccinated, and if so, when? These are all questions Dr. Peter Buch addresses with Dr. Asher Kornbluth, Clinical Professor of Medicine and Gastroenterology at Mount Sinai School of Medicine in New York, to help us optimize our approach to care amid the COVID-19 pandemic.

Host: Neilanjan Nandi, MD

Guest: Jessica Allegretti, MD, MPH

Also known as C. diff for short, Clostridium difficile is an extremely difficult intestinal disease to manage…but not an impossible one. Joining Dr. Neil Nandi to share her insights on how to best mange C. diff in IBD patients is Dr. Jessica Allegretti, the Associate Director of the Crohn's and Colitis Center and the Director of the Fecal Microbiota Transplant Program at the Brigham and Women's Hospital in Boston, Massachusetts.

Host: Neilanjan Nandi, MD

Guest: Jessica Allegretti, MD, MPH

Bezlotoxumab is an IV antitoxin infusion treatment option for Clostridium difficile (C. diff) that’s been shown to reduce recurrence in IBD patients…so why isn’t it being used as much as it should be? Here to share the latest data and insights on bezlotoxumab as a treatment option for IBD patients with C. diff is Dr. Jessica Allegretti, Associate Director of the Crohn's and Colitis Center and Director of the Fecal Microbiota Transplant Program at the Brigham and Women's Hospital in Boston, Massachusetts.

Host: Jennifer Shu, MD, FAAP

Guest: Ramiz Kseri, MD

Without an available vaccine, our pediatric patients can transmit COVID-19. With that in mind, how should pediatric practices adapt? Joining Dr. Jennifer Shu to discuss the impact of COVID-19 on pediatric care is Dr. Ramiz Kseri, a dually board-certified Internist and Pediatrician and an Assistant Professor of Clinical Sciences at Florida State University College of Medicine

Host: Jennifer Shu, MD, FAAP

Guest: Ramiz Kseri, MD

What are some factors leading to disparities in care for our LGBTQ patients, and how do we keep them safe amid the pandemic? Dr. Jennifer Shu is joined by Dr. Ramiz Kseri, an Internist and Pediatrician and an Assistant Professor of Clinical Sciences at Florida State University College of Medicine, to discuss how the LGBTQ community is affected by COVID-19 and other health risks.